Related Experiment Video

Updated: May 14, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Inhibition of P-glycoprotein mediated multidrug resistance by stemofoline derivatives

Sonthaya Umsumarng1, Komsak Pintha, Pornsiri Pitchakarn

  • 1Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Chemical & Pharmaceutical Bulletin
|January 30, 2013
PubMed

Insights

Stemofoline derivatives show promise in reversing multidrug resistance in cancer cells by inhibiting P-glycoprotein (P-gp) efflux pumps. These compounds enhance chemotherapy effectiveness, offering potential as chemosensitizers for resistant cancers.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Multidrug resistance (MDR) in cancer is often mediated by ATP-binding cassette (ABC) transporters, particularly P-glycoprotein (P-gp).
  • P-gp overexpression leads to active efflux of chemotherapeutic agents, reducing treatment efficacy.
  • Novel strategies are needed to overcome P-gp-mediated MDR.

Purpose of the Study:

  • To synthesize and evaluate stemofoline derivatives for their ability to reverse P-gp-mediated multidrug resistance.
  • To assess the chemosensitizing potential of these derivatives in drug-resistant cancer cell lines.

Main Methods:

  • Synthesis of didehydrostemofoline and eleven derivatives.
  • Cytotoxicity and drug sensitivity assays (MTT) were performed on drug-resistant (KB-V1, K562/Adr) and sensitive (KB-3-1, K562) cell lines.
  • Evaluation of the effect of derivatives on doxorubicin, vinblastine, and paclitaxel sensitivity.

Main Results:

  • Three stemofoline derivatives (OH-A1, NH-B6, NH-D6) demonstrated significant reversal of resistance in KB-V1 cells against doxorubicin, vinblastine, and paclitaxel.
  • These derivatives also increased sensitivity to doxorubicin and paclitaxel in K562/Adr cells.
  • No significant effects were observed in the parental drug-sensitive cell lines.

Conclusions:

  • Stemofoline derivatives effectively reverse P-glycoprotein-mediated multidrug resistance in vitro.
  • These compounds hold potential as chemosensitizers for treating multidrug-resistant cancers.
  • Further investigation into the molecular mechanisms of P-gp modulation is warranted.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...